You are here: Industry Insights > COPD

News List

FDA Grants Tentative Approval to Generic Version of Symbicort contractpharma
March 10, 2021
Product is indicated for certain patients with asthma or chronic obstructive pulmonary disease (COPD).
CHMP opinions: EMA refuses asthma label expansion for GSK’s COPD drug Trelegy Ellipta pharmaceutical-technology
March 02, 2021
The European Union’s healthcare regulator the European Medicines Agency (EMA) has decided against a label expansion for GlaxoSmithKline (GSK)’s drug Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) to include asthma.
Gala Therapeutics Receives FDA Approval for RheOx Trial for Chronic Bronchitis americanpharmaceuticalreview
February 25, 2021
Gala Therapeutics has announced the U.S. Food and Drug Administration (FDA) conditional Investigational Device Exemption (IDE) approval to commence its pivotal clinical trial called RheSolve, which is designed to evaluate the ...
Inhaled hyaluronan shows promise in COPD europeanpharmaceuticalreview
February 03, 2021
A study shows inhaling hyaluronan is effective as a treatment for severe flares of chronic obstructive pulmonary disease (COPD).
Chiesi Group Receives EMA for Triple-Combination Therapy Asthma americanpharmaceuticalreview
February 02, 2021
Chiesi announced the European Commission has granted the marketing authorization for Chiesi extrafine triple therapy combination ICS/LABA/LAMA in a single inhaler, for the treatment of asthma.
EU for AZ' COPD maintenance therapy pharmatimes
December 15, 2020
AstraZeneca’s Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) has been approved in the EU for maintenance treatment in adults with moderate to severe chronic obstructive pulmonary disease (COPD).
OM Pharma and AstraZeneca Sign Collaboration Agreement contractpharma
November 09, 2020
OM Pharma and AstraZeneca finalized a strategic collaboration agreement today at a partnership signing ceremony in Shanghai.
AptarGroup Acquires Assets of Cohero Health contractpharma
November 06, 2020
AptarGroup Inc., an expert in consumer dispensing, active packaging, drug delivery solutions and services, has acquired all operating assets and the proprietary portfolio of Cohero Health Inc., a digital therapeutics company transforming respiratory ...
Zydus Cadila launches COPD drug in India expresspharma
October 09, 2020
Forglyn pMDI is priced at Rs 495 per pack and has been developed in-house using Zydus’ innovations in formulation technology.
Verona Pharma launches late-stage COPD trial programme pharmatimes
September 27, 2020
Verona Pharma has initiated phase III trials to evaluate the safety and efficacy of nebulised ensifentrine in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD).

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page